• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
7.32% 7.6¢

IMMURON LIMITED - Charts / Financials

Market Cap $17.41M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.08pm 18/10/2024 (20 minute delay) ?
Day
Open 8.0¢   Day High 8.1¢   Day Low 7.6¢
Daily Volume 1756703
Bids   Sellers
Number Price Volume   Number Price Volume
2 7.6¢ 57477   1 7.8¢ 1417

Directors & Senior Management

Mr. Steven Lydeamore Chief Executive Officer
Mr. Phillip Hains Chief Financial Officer, Company Secretary
Dr. Jerry Kanellos Chief Operating Officer
Mr. Paul Brennan Non-Executive Independent Chairman of the Board
Dr. Jeannette Joughin Non-Executive Director
Mr. Daniel Pollock Non-Executive Independent Director
Prof. Ravi Savarirayan Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
7.6¢ 		Change
-0.006(7.32%) 		Mkt cap ! $17.41M
Open High Low Value Volume
8.0¢ 8.1¢ 7.6¢ $138.6K 1.756M

Buyers (Bids)

No. Vol. Price($)
2 57477 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.8¢ 1417 1
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
Last
7.7¢ 		  Change
-0.006 ( 4.94 %)
Open High Low Volume
8.0¢ 8.0¢ 7.6¢ 711302
Last updated 15.08pm 18/10/2024 ?

Top Stories

Macro, Norden set up transport solutions initiative for West Pilbara

Macro Metals Ltd has signed a Memorandum of Understanding with Danish company Norden to develop a comprehensive transport solution
Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war What HotCopper watched on the ASX this week felt a bit like 2022 – a lithium explorer and a battery anode developer won the cake.
Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9% Swoop Holdings (ASX:SWP) has lobbed an off-market takeover offer at Vonex (ASX:VN8) with an implied price of 5cps.
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint Let’s get straight to the point: of all the smallcaps in the Telecommunications index, The Market Ltd could be one of the most overlooked.
Nanoveu surges 10% after benchmark testing for new AI chip begins Nanoveu has surged this week after the nanotechnology developer's soon-to-be-acquired Embedded A.I. Systems started chip testing.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.